Company news
Resonance Health Ltd news in 2018
Resonance Health Ltd's news releases, calls and decks from 2018, newest first.
Response to ASX Price and Volume Query
December 11, 2018
FDA Clearance Granted for FerriSmart
December 2, 2018
R&D Tax Incentive
November 20, 2018
R&D Tax Incentive
November 19, 2018
Change of Director's Interest Notice
November 15, 2018
New Work Order to provide services for Clinical Trial
October 31, 2018
Pause in Trading
October 22, 2018
Change of Substantial Shareholder Notification
September 6, 2018
Additional Information on Announcement Dated 23 August 2018
August 27, 2018
Resonance Health contracted for two new clinical trials
August 23, 2018
TGA, CE Mark clearance for A.I. Solution FerriSmart
July 10, 2018
Alliance Partner Agreement with Blackford Analysis
July 5, 2018
Additional Info. in relation to 4 May 2018 announcement
May 4, 2018
Resonance Deal to distribute Diabetic Retinopathy AI tool
May 3, 2018
Appointment of CEO
February 23, 2018
RHT Develops new assessment for the screening of NASH
February 20, 2018
Resonance Health contracted for new clinical trial
February 12, 2018
FerriScan contracted for two new Clinical Trials
January 12, 2018
Decks in 2018
- Shareholder Meeting (November 2018)
Shareholder meeting · 8 slides · Nov 8, 2018
- Investor Presentation (June 2018)
Investor deck · 18 slides · Jun 12, 2018